VITAMIN BLUE INC

As of September 30, 2013, VITAMIN BLUE INC carries a market capitalization of 1.62M, placing it among publicly traded companies globally. Its enterprise value stands at 1.92M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of September 30, 2013, VITAMIN BLUE INC has 738.41M shares outstanding.

These figures are as of September 30, 2013. The price-to-sales ratio is 9.22, and the price-to-book ratio stands at -1.82.

These figures are as of September 30, 2013. The EV/Sales ratio of 13.14 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 1.92M versus a market cap of 1.62M, with the gap driven by net debt and cash on the balance sheet.

As of September 30, 2013, VITAMIN BLUE INC maintains a current ratio of 0.04, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -33.63, indicating conservative leverage, while an interest coverage ratio of -0.42 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended September 30, 2013. Return on assets (ROA) is negative at -2,530.26, reflecting losses generated across the asset base. Inventory turnover of 7.77 indicates how many times VITAMIN BLUE INC sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended September 30, 2013, VITAMIN BLUE INC generated 146,214.00 in revenue and converted that into -1.28M in net income, yielding earnings per share of 0.00. EBITDA reached -112,373.00, while operating income came in at -113,749.00.

As of September 30, 2013, VITAMIN BLUE INC holds 2,522.00 in cash and equivalents against 299,365.00 in total debt, resulting in a net debt position of 296,843.00. Total book value stands at -890,181.00, with working capital of -900,772.00 providing operational flexibility.

VITAMIN BLUE INC produced -72,825.00 in operating cash flow over the twelve months ended September 30, 2013.

Over the twelve months ended September 30, 2013, VITAMIN BLUE INC posted a gross margin of 41.20, reflecting its pricing power and cost economics. The operating margin of -77.80 and net profit margin of -876.13 provide insight into operational efficiency.

These figures cover the twelve months ended September 30, 2013. Free cash flow yield is negative at -5.40: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -4.62, meaning VITAMIN BLUE INC raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of September 30, 2013, VITAMIN BLUE INC has an Altman Z-Score of -96.49, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.